Simplex Trading, LLC Revance Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $3.28 Billion
  • Q4 2024

A detailed history of Simplex Trading, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 38,598 shares of RVNC stock, worth $99,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,598
Previous 24,378 58.33%
Holding current value
$99,196
Previous $62,000 59.68%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
N/A
14,220 Added 58.33%
38,598 $99,000
Q3 2024

Nov 08, 2024
SELL
$2.57 - $2.57 $86,722 - $86,722
-33,744 Reduced 58.06%
24,378 $62,000
Q2 2024

Jul 25, 2024
BUY
$2.34 - $4.73 $136,005 - $274,917
58,122 New
58,122 $149,000
Q3 2023

Nov 01, 2023
BUY
$11.47 - $25.07 $29,994 - $65,558
2,615 Added 15.98%
18,980 $217,000
Q2 2023

Aug 04, 2023
BUY
$24.7 - $37.61 $19,364 - $29,486
784 Added 5.03%
16,365 $414,000
Q1 2023

Apr 27, 2023
BUY
$18.36 - $35.27 $41,493 - $79,710
2,260 Added 16.97%
15,581 $501,000
Q4 2022

Feb 02, 2023
SELL
$18.32 - $30.66 $628,009 - $1.05 Million
-34,280 Reduced 72.02%
13,321 $245,000
Q3 2022

Nov 04, 2022
BUY
$14.33 - $28.47 $449,603 - $893,246
31,375 Added 193.36%
47,601 $1.29 Million
Q2 2022

Aug 03, 2022
SELL
$11.52 - $20.4 $133,954 - $237,211
-11,628 Reduced 41.75%
16,226 $224,000
Q1 2022

May 02, 2022
BUY
$12.36 - $20.31 $344,275 - $565,714
27,854 New
27,854 $543,000
Q2 2021

Aug 12, 2021
SELL
$26.8 - $31.84 $81,659 - $97,016
-3,047 Closed
0 $0
Q1 2021

Apr 26, 2021
SELL
$24.03 - $29.97 $85,186 - $106,243
-3,545 Reduced 53.78%
3,047 $85,000
Q4 2020

Feb 02, 2021
SELL
$23.41 - $28.34 $25,704 - $31,117
-1,098 Reduced 14.28%
6,592 $186,000
Q3 2020

Oct 14, 2020
BUY
$23.23 - $34.3 $178,638 - $263,767
7,690 New
7,690 $193,000
Q1 2020

Apr 29, 2020
SELL
$12.46 - $27.81 $109,822 - $245,117
-8,814 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$11.66 - $20.15 $61,821 - $106,835
5,302 Added 150.97%
8,814 $143,000
Q3 2019

Oct 15, 2019
SELL
$10.22 - $14.5 $725 - $1,029
-71 Reduced 1.98%
3,512 $45,000
Q2 2019

Jul 26, 2019
BUY
$10.67 - $15.49 $38,230 - $55,500
3,583 New
3,583 $46,000
Q4 2018

Jan 16, 2019
SELL
$18.06 - $24.96 $34,259 - $47,349
-1,897 Closed
0 $0
Q3 2018

Oct 23, 2018
SELL
$23.55 - $30.1 $3,626 - $4,635
-154 Reduced 7.51%
1,897 $47,000
Q2 2018

Jul 30, 2018
SELL
$27.45 - $33.35 $7,576 - $9,204
-276 Reduced 11.86%
2,051 $56,000
Q1 2018

Apr 26, 2018
BUY
$29.15 - $37.4 $67,832 - $87,029
2,327 New
2,327 $71,000
Q4 2017

Jan 10, 2018
SELL
$24.55 - $36.3 $111,923 - $165,491
-4,559 Closed
0 $0
Q3 2017

Oct 25, 2017
BUY
$22.55 - $28.1 $102,805 - $128,107
4,559
4,559 $125,000

Others Institutions Holding RVNC

# of Institutions
219
Shares Held
77.6M
Call Options Held
2.18M
Put Options Held
5.27M
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email